[In vivo evaluation of the new antithrombogenic reservoir-catheter coated with polymer blend copolymer].
We evaluated the antithrombogenicity of 4F-catheters coated with the new antithrombogenic material fluorine-acryl- styrene-urethane-silicone (FASUS) graft-block copolymer by dissecting microscopic and scanning electron microscopic observations. These catheters were temporarily used for the infusa-A-port, which was prepared for the treatment of four patients with bladder cancer. Two heparin-coated catheters were also evaluated. All FASUS-coated catheters contained thrombi consisting of red thrombi and/or fibrin thrombi. Massive red thrombus was seen at the site of curvature of the catheters, 1 cm distal to the tip of the catheter. However, the portion 20 cm distal to the tip of the catheter had no red thrombus, but contained minimal fibrin thrombus or plasma protein. The heparin-coated catheters showed the same findings as the FASUS catheters. The FASUS-coated catheters were not superior in antithrombogenicity to the heparin-coated catheters. It was concluded that the FASUS-coated catheters used in this study seemed to have problems in regard to their preshaped curvature and the material used in catheter. These aspects need to be improved.
Matsumoto
S
S
Department of Radiology, Oita Medical University.
Yamada
Y
Y
Kiyosue
H
H
Dono
S
S
Mori
H
H
Imagawa
M
M
Nomura
Y
Y
Toyoda
H
H
Shimada
T
T
D000368:Aged; D002404:Catheterization / Q000295:instrumentation / Q000592:standards*; D005069:Evaluation Studies as Topic; D006493:Heparin; D006801:Humans; D015918:Infusion Pumps, Implantable / Q000592:standards*; D008297:Male; D008875:Middle Aged; D011108:Polymers; D013927:Thrombosis / Q000517:prevention & control*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy
D011108:Polymers; D006493:Heparin